Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Whole-genome CRISPR screening identifies genetic manipulations to reduce immune rejection of stem cell-derived islets
Elad Sintov, Igor Nikolskiy, Víctor Barrera, et al.
Stem Cell Reports (2022) Vol. 17, Iss. 9, pp. 1976-1990
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes
Nathaniel J. Hogrebe, Matthew Ishahak, Jeffrey R. Millman
Cell stem cell (2023) Vol. 30, Iss. 5, pp. 530-548
Open Access | Times Cited: 87
Engineering human stem cell-derived islets to evade immune rejection and promote localized immune tolerance
Dario Gerace, Quan Zhou, Jennifer Hyoje-Ryu Kenty, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 1, pp. 100879-100879
Open Access | Times Cited: 48
Single-nucleus multi-omics of human stem cell-derived islets identifies deficiencies in lineage specification
Punn Augsornworawat, Nathaniel J. Hogrebe, Matthew Ishahak, et al.
Nature Cell Biology (2023) Vol. 25, Iss. 6, pp. 904-916
Open Access | Times Cited: 35
Why does the immune system destroy pancreatic β-cells but not α-cells in type 1 diabetes?
Décio L. Eizirik, Florian Szymczak, Roberto Mallone
Nature Reviews Endocrinology (2023) Vol. 19, Iss. 7, pp. 425-434
Closed Access | Times Cited: 32
Current trends of clinical trials involving CRISPR/Cas systems
Song‐Yang Zhang, Yidi Wang, Dezhi Mao, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 24
Current status of stem cell therapy for type 1 diabetes: a critique and a prospective consideration
Mohamed A. Ghoneim, Mahmoud M. Gabr, Sawsan M. El-Halawani, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Advances in Nanoparticles as Non-Viral Vectors for Efficient Delivery of CRISPR/Cas9
Minse Kim, Youngwoo Hwang, Seongyu Lim, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1197-1197
Open Access | Times Cited: 9
Genetically engineered hypoimmunogenic cell therapy
Akitsu Hotta, Sonja Schrepfer, András Nagy
Nature Reviews Bioengineering (2024) Vol. 2, Iss. 11, pp. 960-979
Closed Access | Times Cited: 8
A spectacular year for islet and stem cell transplantation
A. M. James Shapiro, Kevin Verhoeff
Nature Reviews Endocrinology (2022) Vol. 19, Iss. 2, pp. 68-69
Closed Access | Times Cited: 26
Encapsulation and immune protection for type 1 diabetes cell therapy
Sophia Kioulaphides, Andrés J. Garcı́a
Advanced Drug Delivery Reviews (2024) Vol. 207, pp. 115205-115205
Closed Access | Times Cited: 5
Advancements and Challenges in Immune Protection Strategies for Islet Transplantation
Xue Wang, Ziyuan Zeng, Dayan Li, et al.
Journal of Diabetes (2025) Vol. 17, Iss. 1
Open Access
Islet Cell Replacement and Regeneration for Type 1 Diabetes: Current Developments and Future Prospects
Arthur Rech Tondin, Giacomo Lanzoni
BioDrugs (2025)
Open Access
The efficiency of stem cell differentiation into functional beta cells for treating insulin-requiring diabetes: Recent advances and current challenges
Yunfei Luo, Peng Yu, Jianping Liu
Endocrine (2024) Vol. 86, Iss. 1, pp. 1-14
Closed Access | Times Cited: 3
Applications of Genome-Editing Technologies for Type 1 Diabetes
Rana El Nahas, Mohammad Ameen Al‐Aghbar, Laura Herrero, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 344-344
Open Access | Times Cited: 8
Genetic Engineering of Immune Evasive Stem Cell-Derived Islets
Sara Dutton Sackett, Samuel J. Kaplan, Samantha A. Mitchell, et al.
Transplant International (2022) Vol. 35
Open Access | Times Cited: 13
Recent progress in modeling and treating diabetes using stem cell-derived islets
Marlie M. Maestas, Maggie H Bui, Jeffrey R. Millman
Stem Cells Translational Medicine (2024) Vol. 13, Iss. 10, pp. 949-958
Open Access | Times Cited: 2
Precision Medicine in Type 1 Diabetes
Dominika Michałek, Suna Önengüt-Gümüşcü, David R. Repaske, et al.
Journal of the Indian Institute of Science (2023) Vol. 103, Iss. 1, pp. 335-351
Open Access | Times Cited: 6
Human A2-CAR T Cells Reject HLA-A2+ Human Islets Transplanted Into Mice Without Inducing Graft-versus-host Disease
Cara E. Ellis, Majid Mojibian, Shogo Ida, et al.
Transplantation (2023)
Open Access | Times Cited: 6
Islet cells in human type 1 diabetes: from recent advances to novel therapies – a symposium-based roadmap for future research
James Cantley, Décio L. Eizirik, Esther Latres, et al.
Journal of Endocrinology (2023) Vol. 259, Iss. 1
Open Access | Times Cited: 5
Non-invasive quantification of stem cell-derived islet graft size and composition
Väinö Lithovius, Salla Lahdenpohja, Hazem Ibrahim, et al.
Diabetologia (2024)
Open Access | Times Cited: 1
Genome-scale CRISPR-Cas9 screening in stem cells: theories, applications and challenges
Heng Zhou, Ye Peng, Wei Xiong, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Defining the chromatin and transcriptional landscape of stem cell-derived islets
Punn Augsornworawat, Nathaniel J. Hogrebe, Matthew Ishahak, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Functional genomics in stem cell models: considerations and applications
Kaivalya Shevade, Sailaja Peddada, K. Mäder, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 2
Genome editing for engineering stem cell-derived pancreatic β cells: recent trends and future perspectives
Seeun Jang, Siyoon Shin, Yujin Jeong, et al.
Organoid (2023) Vol. 3, pp. e16-e16
Open Access | Times Cited: 2
CRISPR-MIP replaces PCR and reveals GC and oversampling bias in pooled CRISPR screens
Martin Selinger, Iryna Yakovenko, Iqra Nazir, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1 - Next Page

Scroll to top